Revolutionary peptide used in Alzheimers & Diabetes research now available worldwide to club members
1888PressRelease - British price breakthrough on Humanin S14G sold as dietary supplement.
Humanin S14G is offered worldwide as a dietary supplement spray ready formulated to members of the Mackenzie Protocol Co-researchers Club.
Additionally, they can now also opt to buy the lyophilised powder in 10mg vials at a vastly lower price than previously available from traditional peptide synthesis laboratories. This allows researchers to formulate their own products if they wish.
Humanin was first discovered around the turn of the 21st century. It has since been widely touted by scientists worldwide as a revolutionary and potentially effective therapy for Alzheimer's, diabetes, and other neuropathic conditions.
However, as a dietary supplement the manufacturer is unable to legally make any claim for the new product as is normal for all dietary supplements. Links to the scientific background of the discovery are given on their new website at http://www.humanins14g.com
Advantage Impex co UK Ltd is a specialist manufacturer of anti ageing supplement products. They operate as the Mackenzie Protocol and 21st Century Alternatives. They were the first British company to manufacture and distribute worldwide a competitively priced cycloastragenol based herbal supplement whilst still maintaining a high level of purity.
They now claim another British first with a dietary supplement spray called NeuroPep (UK) (tm) containing humanin S14G which is a revolutionary synthesised polypeptide found in the human body.
However, the manufacturer only offer their products to their own co-researcher club members and not the general public. Membership is free for non consumers expressing a genuine desire to research and test the supplement and a reseller club is also available for quantity purchasers interested in handling all their products at a discount. The discounted reseller items start at quantities of only 12 mixed items and are available worldwide.
About the Author
The Mackenzie Protocol PLC is a new UK company set up as a result of recent research resulting in the 2009 Nobel prize in Physiology or Medicine. It will be marketing the Mackenzie Protocol global anti aging trials based on the cutting edge science of telomeres and the activation of the enzyme telomerase.
Submitted on: 2014-11-13 20:20:21